Physician profile
Nakul Ravikumar
NPI 1871933119
$33,511.63
in general payments reported to CMS, 2019-2025
15 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $204 · 2022: $750 · 2023: $32K · 2024: $489 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Food and Beverage: $2,284 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Food and Beverage | $2,284.35 |
| Travel and Lodging | $273.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,050.23 | 2022-2023 | Expect |
| Noah Medical Corporation | $1,521.15 | 2023-2025 | Galaxy |
| Pinnacle Biologics, INC | $394.66 | 2022 | |
| Pulmonx Corporation | $289.63 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Olympus America INC. | $230.01 | 2023 | Spiration Valve System |
| Ambu INC. | $209.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $205.09 | 2023 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $144.98 | 2020-2023 | Nucala |
| Portola Pharmaceuticals, LLC | $124.35 | 2020 | |
| Amgen INC. | $102.68 | 2023 | Tezspire |
| Galvanize Therapeutics, INC | $85.01 | 2023 | Aliya System |
| Ethicon INC. | $46.13 | 2022 | |
| Olympus Corporation of The Americas | $43.86 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.99 | 2022-2023 | Glassia |
| Genentech USA, INC. | $23.40 | 2023 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nakul Ravikumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.